TABLE 2.
Summary of investigator‐assessed measures for the symptoms and severity of rosacea
| Measures | Phase 3 full analysis set (N = 130) |
|---|---|
| Inflammatory lesions (papules + pustules) | |
| Range, n (%) | |
| 11–20 | 64 (49.2) |
| 21–30 | 28 (21.5) |
| 31–40 | 38 (29.2) |
| Number, mean (SD) | 23.7 (9.3) |
| Number of papules, mean (SD) | 21.1 (8.6) |
| Number of pustules, mean (SD) | 2.7 (3.9) |
| Erythema severity, n (%) | |
| Mild (score 2) | 28 (21.5) |
| Moderate (score 3) | 79 (60.8) |
| Severe (score 4) | 23 (17.7) |
| IGA, n (%) | |
| Moderate (score 3) | 114 (87.7) |
| Severe (score 4) | 16 (12.3) |
Abbreviations: IGA, Investigator Global Assessment; SD, standard deviation.